4
Changes in Ownership
Rein Therapeutics, Inc. Filed Acc 0000899243-17-018014
Director bought 273,333 shares at $15.00 ($4,099,995)
- Director acquired 1,158,186 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Gallagher Brian M. Jr. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-05 | Conversion : show line 1 in the form | +1,158,186 | 1,158,186 | I | ||
| 2017-07-05 | Purchase : show line 2 in the form | +273,333 | $15.00 | $4,099,995 | 1,431,519 | I |
| Open-market purchases · 273,333 sh · avg $15.00 · $4,099,995 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-07-05 | Conversion : show line 3 in the form Series D Preferred Stock | −6,781,770 | 0 | I |
| 2017-07-05 | Conversion : show line 4 in the form Series E-2 Preferred Stock | −1,471,551 | 0 | I |
| 2017-07-05 | Conversion : show line 5 in the form Series E-3 Preferred Stock | −1,276,389 | 0 | I |
| 2017-07-05 | Conversion : show line 6 in the form Series F Preferred Stock | −1,979,188 | 0 | I |
Loading xslF345X03/doc4.xml…